Trial Profile
A phase III trial to determine the efficacy and safety of an extended regimen of nevirapine in infants born to HIV-infected women to prevent vertical HIV transmission during breastfeeding
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Oct 2023
Price :
$35
*
At a glance
- Drugs Cotrimoxazole (Primary) ; Nevirapine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 18 Oct 2023 Results post-hoc analysis describing the clinical and virologic characteristics of HIV-HBV coinfection, including the predictors of high maternal HBV viral load in pregnant women with HIV in sub-Saharan Africa, published in the AIDS
- 07 Mar 2019 Results presented at the 26th Conference on Retroviruses and Opportunistic Infections
- 06 Mar 2013 Final results at 18 months presented at the 20th Conference on Retroviruses and Opportunistic Infections.